Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis
Publication date
2021-07-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Nephropathic cystinosis is a severe, monogenic systemic disorder that presents early in life and leads to progressive organ damage, particularly affecting the kidneys. It is caused by mutations in the CTNS gene, which encodes the lysosomal transporter cystinosin, resulting in intralysosomal accumulation of cystine. Recent studies demonstrated that the loss of cystinosin is associated with disrupted autophagy dynamics, accumulation of distorted mitochondria, and increased oxidative stress, leading to abnormal proliferation and dysfunction of kidney cells. We discuss these molecular mechanisms driving nephropathic cystinosis. Further, we consider how unravelling molecular mechanisms supports the identification and development of new strategies for cystinosis by the use of small molecules, biologicals, and genetic rescue of the disease in vitro and in vivo.
Keywords
CTNS gene, cystinosis, lysosomal storage disorder, renal Fanconi syndrome, therapeutic strategies, Taverne, Molecular Medicine, Molecular Biology
Citation
Jamalpoor, A, Othman, A, Levtchenko, E N, Masereeuw, R & Janssen, M J 2021, 'Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis', Trends in Molecular Medicine, vol. 27, no. 7, pp. 673-686. https://doi.org/10.1016/j.molmed.2021.04.004